Targeting The Mitochondrial Functional Network: Decoding Upstream Pathological Mechanisms And Novel Therapeutic Paradigms For Alzheimer’S Disease
Scientists are increasingly recognizing the crucial role of mitochondria, the powerhouses of our cells, in the development and progression of Alzheimer’s disease. Dysfunction in these tiny organelles can lead to a cascade of problems, including increased cellular stress, impaired energy production, and issues with calcium regulation, all of which contribute to the damage seen in Alzheimer’s brains. This mitochondrial malfunction is also closely linked to the accumulation of abnormal proteins like amyloid-beta and tau, which are hallmarks of the disease. Researchers are exploring innovative ways to intervene by focusing on these mitochondrial issues. Potential strategies include boosting the number and activity of healthy mitochondria, transplanting functional mitochondria into damaged cells, and using specialized therapies that target specific mitochondrial processes. For instance, one promising approach involves designing smart drug delivery systems, like tiny micelles, that can specifically deliver therapeutic agents to mitochondria in brain cells, helping to reduce inflammation and improve cognitive function. By understanding and addressing these fundamental cellular energy problems, new avenues for treating this complex neurodegenerative condition are emerging.
Source: link to paper